CIK 0001863127
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Tyra Biosciences, Inc.
Sign in to watch- Ticker
- TYRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831476348
- Phone
- +1 619-728-4760
- Business address
- 2656 STATE STREET, CARLSBAD, CA, 92008
- Open-market buys, last 90 days
- $20,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$20,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-17 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +1,250,000 | $16.00 | $20.0M | 5,297,120 |
| 2021-09-17 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion | +1,496,613 | 1,496,613 | ||
| 2021-09-17 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion | +442,721 | 442,721 | ||
| 2021-09-17 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion · Series A Preferred Stock | −1,011,370 | 0 | ||
| 2021-09-17 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion · Series A Preferred Stock | −393,940 | 0 | ||
| 2021-09-17 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion · Series A Preferred Stock | −170,448 | 0 | ||
| 2021-09-17 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion · Series B Preferred Stock | −546,773 | 0 | ||
| 2021-09-17 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion · Series B Preferred Stock | −182,257 | 0 | ||
| 2021-09-17 | Bensen Daniel Chief Operating Officer | Conversion | +8,501 | 527,981 | ||
| 2021-09-17 | Bensen Daniel Chief Operating Officer | Conversion · Series A Preferred Stock | −3,273 | 0 | ||
| 2021-09-17 | MORE ROBERT J Director | Conversion | +3,811,117 | 3,924,046 | ||
| 2021-09-17 | MORE ROBERT J Director | Purchase | +156,250 | $16.00 | $2.5M | 4,080,296 |
| 2021-09-17 | MORE ROBERT J Director | Conversion · Series A Preferred Stock | −1,212,122 | 0 | ||
| 2021-09-17 | MORE ROBERT J Director | Conversion · Series B Preferred Stock | −255,160 | 0 | ||
| 2021-09-17 | Alta Partners NextGen Fund II Management, LLC 10% owner | Conversion | +3,811,117 | 3,924,046 | ||
| 2021-09-17 | Alta Partners NextGen Fund II Management, LLC 10% owner | Purchase | +156,250 | $16.00 | $2.5M | 4,080,296 |
| 2021-09-17 | Alta Partners NextGen Fund II Management, LLC 10% owner | Conversion · Series A Preferred Stock | −1,212,122 | 0 | ||
| 2021-09-17 | Alta Partners NextGen Fund II Management, LLC 10% owner | Conversion · Series B Preferred Stock | −255,160 | 0 | ||
| 2021-09-17 | van den Boom Esther Chief Financial Officer | Conversion | +21,254 | 21,254 | ||
| 2021-09-17 | van den Boom Esther Chief Financial Officer | Conversion · Series A Preferred Stock | −8,183 | 0 |
Page 20 of 21 · 417 trades